Home/ Supplements/ Nac/ NAC (N-Acetyl-Cysteine) 600 mg

NAC (N-Acetyl-Cysteine) 600 mg

product on market Capsule Swiss BioEnergetics Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

N-Acetyl Cysteine serves as a precursor to glutathione, a key antioxidant used to support cellular health and detoxification. There is strong research evidence supporting its role in reducing oxidative stress and managing respiratory mucus. The ingredient profile is associated with a high safety rating.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for NAC (N-Acetyl-Cysteine) 600 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
120
Servings
Non-Nutrient/Non-Botanical
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 600.0mg (7 products) 39 studies (A:2, B:13)

Other Ingredients

N-Acetyl Cysteine Maltodextrin Hydroxypropyl Methylcellulose Magnesium Stearate Silicon Dioxide Ingredients
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Directions: Adults, take 1 capsule, 1-2 x daily, with water ideally between meals. Do not exceed recommended daily dose.

Warnings & Precautions

Do not exceed recommended daily dose.

Allergy advice: Potential allergens contained in this product are shown in bold in the ingredient list. Although rigorous precautions are taken to prevent any cross-contamination, this product is manufactured in a facility that handles allergy-based materials.

Cautions: Always consult your health practitioner before taking nutritional supplements, especially if you are taking medication or are under medical supervision.

You should not take supplements as a substitute for a varied balanced diet or healthy lifestyle.

Store in a cool dry place, out of reach of children.

Formulation Notes

Highly bioavailable form stable L-Cysteine

Suitable for vegetarians or vegans

Additional Information

Manufactured in the UK GMP Consistent Quality

Store in a cool dry place, out of reach of children.

Best before: For best before end and batch number see base.

Metadata

Product Details

UPC / SKU5 060361 463475
DSLD Entry Date2023-05-24
Product TypeNon-Nutrient/Non-Botanical
FormCapsule
DSLD ID284297
Data Updated2026-04-11
Research

Research Evidence

41
Research Sources
51
Avg Quality
19
Rct
13
Meta Analysis
9
Clinical Trial
B N-acetylcysteine as an adjuvant therapy for Helicobacter pylori eradication
Meta Analysis The Cochrane database of systematic reviews 2019 PubMed DOI
B Effect of high-dose N-acetylcysteine on exacerbations and lung function in patients with mild-to-moderate COPD: a double-blind, parallel group, multicentre randomised clinical trial
Rct Nature communications 2024 PubMed DOI
B N-acetylcysteine for non-paracetamol (acetaminophen)-related acute liver failure
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
B Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis
Meta Analysis European respiratory review : an official journal of the European Respiratory Society 2015 PubMed DOI
B A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo
Rct BMC medicine 2019 PubMed DOI
B Efficacy of N-acetylcysteine for patients with depression: An updated systematic review and meta-analysis
Meta Analysis General hospital psychiatry 2024 PubMed DOI
B Cysteine, cystine or N-acetylcysteine supplementation in parenterally fed neonates
Meta Analysis The Cochrane database of systematic reviews 2006 PubMed
B N-acetylcysteine as an adjunctive treatment for bipolar depression: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Bipolar disorders 2021 PubMed DOI
B N-acetylcysteine as an adjunctive treatment for bipolar depression and major depressive disorder: a systematic review and meta-analysis of double-blind, randomized placebo-controlled trials
Meta Analysis Psychopharmacology 2020 PubMed DOI
B N-acetylcysteine Treatment in Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis/Pre-COPD: Distinct Meta-analyses
Meta Analysis Archivos de bronconeumologia 2024 PubMed DOI
View all evidence for Nac →
Compare

Similar Products

View all Nac products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.